Malignant Melanoma
New therapy promising for melanoma skin cancerThe combination of two different biotherapies (interferon alfa-2b and tremelimumab) may be beneficial for patients with inoperable melanoma, revealed by researchers in US.
New melanoma gene close to be identifiedThe researchers are close to discovering a new gene that could help explain variation in melanoma risk. They have identified a region on chromosome 20 (20q11.22) that influences a person's risk of developing melanoma.
International Cancer Genome Consortium sets sights on cancerThe International Cancer Genome Consortium (ICGC), which includes the Wellcome Trust and the Wellcome Trust Sanger Institute in the UK, will generate a valuable resource enabling the development of new and better ways of diagnosing, treating and preventing cancer.
Melanoma skin cancer rising in VictoriaNew figures from The Cancer Council Victoria show that the number of Victorians affected by melanoma is at the highest level ever. Latest figures from the Victorian Cancer Registry show that in 2005, melanoma overtook lung cancer and is now the fourth most common cause of cancer in Victorians.
IGFBP7 protein may stop melanoma skin cancerHoward Hughes Medical Institute (HHMI) researchers have uncovered a protein that stops the growth of melanoma, a cancer that develops from pigment-producing cells in the skin called melanocytes.
Melanomas may appear different than other molesA preliminary study suggests that melanomas have a different appearance than other irregular skin moles (i.e., are "ugly ducklings"), according to a report in the January issue of Archives of Dermatology, one of the JAMA/Archives journals.
Newly discovered virus linked to skin cancerResearchers using sequencing technique discovered a new cancer virus Merkel cell polyomavirus (MCV) causing Kaposi's sarcoma, is associated with another rare but deadly skin cancer called Merkel cell carcinoma.